Edgewise Therapeutics Inc...

23.27
-0.17 (-0.73%)
At close: Mar 28, 2025, 3:59 PM
22.77
-2.14%
After-hours: Mar 28, 2025, 06:08 PM EDT

Edgewise Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 1.73M 538K 272K 185K 123K
Gross Profit n/a -1.73M -538K -272K -185K -123K
Operating Income -158.83M -114.36M -22.08M -43.22M -17.19M -9.92M
Interest Income 25.02M 14.19M 2.66M 402K 69K 219K
Pretax Income -133.81M -100.16M -19.41M -42.81M -17.12M -9.71M
Net Income -133.81M -100.16M -15.4M -42.14M -17.05M -9.49M
Selling & General & Admin 31.87M 23.45M 5.47M 11.03M 2.21M 1.3M
Research & Development 126.97M 89.35M 16.61M 32.19M 14.98M 8.62M
Other Expenses n/a n/a n/a n/a n/a n/a
Operating Expenses 158.83M 114.36M 22.08M 43.22M 17.19M 9.92M
Interest Expense n/a n/a 4.02M n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 114.36M 22.08M 43.22M 17.19M 9.92M
Income Tax n/a n/a -4.02M -674K -69K -219K
Shares Outstanding (Basic) 92.41M 63.72M 53.59M 49.5M 49.22M 49.22M
Shares Outstanding (Diluted) 92.41M 63.72M 53.59M 49.5M 49.22M 49.22M
EPS (Basic) -1.45 -1.57 -0.29 -0.85 -0.35 -0.19
EPS (Diluted) -1.45 -1.57 -0.29 -0.85 -0.35 -0.19
EBITDA -158.83M -112.81M -67.1M -42.94M -17.01M -9.8M
Depreciation & Amortization n/a 1.73M 538K 272K 185K 123K